Stock FAQs

why is organigram stock dropping

by Blaze Murazik Published 3 years ago Updated 2 years ago
image

The company has had a massive fall from grace, dropping from $5.66 USD on Monday, to today's current price of $4.31. And the stock continues to drop; down almost 13% on the day. There is no particular reason for this fall other than a market-wide correction.

Full Answer

Who bought organigram stock?

May 03, 2021 · Shares of Canadian cannabis company OrganiGram Holdings ( OGI -3.87% ) dropped Monday after the company told investors the CEO has stepped away from that role. As of 11 a.m. EDT, OrganiGram shares ...

Is organigram efficiently growing its dividend?

Apr 13, 2021 · OrganiGram Holdings ( OGI -3.95% ) reported its fiscal second-quarter 2021 results this morning, and the stock initially dropped 12% on the report. The decline quickly eased, however, with shares ...

Should you hold organigram (Ogi) stock?

Apr 06, 2021 · Canadian marijuana grower OrganiGram Holdings ( OGI -4.29% ) has had an eventful month, as the stock rose about 15% in March. But some investors are taking profits today after the company ...

Is there an upside for organigram stock?

Apr 06, 2021 · Canadian marijuana grower OrganiGram Holdings (NASDAQ: OGI) has had an eventful month, as the stock rose about 15% in March. But some investors are taking profits today after the company announced ...

image

Will OrganiGram stock go up?

and has now fallen 7 days in a row. During the day the stock fluctuated 10.27% from a day low at $1.46 to a day high of $1.61....Predicted Opening Price for OrganiGram Holdings Inc. of Monday, April 25, 2022.Fair opening price April 25, 2022Current price$1.51$1.46 (Undervalued)

Should I sell OrganiGram stock?

OrganiGram has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

Is OrganiGram a good buy?

What's the verdict? With declining sales, huge losses, and no sign of a turnaround, OrganiGram stock is hardly worth the price while trading at 9.8 times revenue. I'd highly recommend checking out U.S. cannabis producer stocks that are growing their sales by over 100%, and trading for better levels.Apr 20, 2021

Is Ogi being shorted?

Stock - Short Squeeze, Short Sale Volume, Borrow Rates, Fails-To-Deliver....Sign Up for a Forever Free Fintel Account.Short Interestshares - source: NASDAQShort Interest Ratio2.33 Days to Cover3 more rows

Is OrganiGram a buy Zacks?

See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows

Who owns OrganiGram?

Organigram Holdings Inc.Corporate Profile. Organigram Holdings Inc., (NASDAQ: OGI) (TSX: OGI), is the parent company of Organigram Inc., a licensed producer of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a cannabis-infused soft chew and confectionery manufacturer in Canada.

When did OGI go public?

January 5, 2012OGI stock went public on January 5, 2012 and ended the day at $0.29. The stock has since gained 1,000%.Feb 14, 2020

Investors initially reacted negatively to the Canadian cannabis company's quarterly results

Howard grew up in Philadelphia watching the Philly sports teams struggle for championships. He has been investing since 1989 and been a Fool since 2001. Prior to joining The Fool as a contract writer in 2019, Howard worked in the steel business as an engineer for 28 years.

What happened

OrganiGram Holdings ( NASDAQ:OGI) reported its fiscal second-quarter 2021 results this morning, and the stock initially dropped 12% on the report. The decline quickly eased, however, with shares trading about 2% lower than Monday's close as of 10:20 a.m. EDT.

So what

The results at first glance did not look positive, but investors likely saw the negative metrics as temporary. OrganiGram CEO Greg Engel noted the business was "challenged by industry dynamics, COVID-19 and staffing limitations at our facility." OrganiGram currently operates a single facility in New Brunswick.

Now what

The marijuana company also highlighted some recent events it believes will significantly help its growth trajectory. Last month, OrganiGram and tobacco giant British American Tobacco ( NYSE:BTI) announced a product development collaboration.

Investors may not like the dilution from a new acquisition

Howard grew up in Philadelphia watching the Philly sports teams struggle for championships. He has been investing since 1989 and been a Fool since 2001. Prior to joining The Fool as a contract writer in 2019, Howard worked in the steel business as an engineer for 28 years.

What happened

Canadian marijuana grower OrganiGram Holdings ( NASDAQ:OGI) has had an eventful month, as the stock rose about 15% in March. But some investors are taking profits today after the company announced a new acquisition has been funded with the sale of about 5 million shares of common stock. As of 10:45 a.m. EDT on Tuesday, shares were down about 5%.

So what

OrganiGram said today that it has acquired The Edibles & Infusions Corporation (EIC), a maker of "highly customizable, precise, and scalable cannabis-infused products, including edibles." The acquisition gives OrganiGram a second operating facility, and a footprint in Western Canada.

Now what

OrganiGram expects to begin sales of EIC soft chews in its fiscal fourth quarter 2021. The acquisition brings exposure to a growing segment of Canada's cannabis market. It said edibles currently make up about 4.4% of the country's recreational cannabis market, mostly in the form of soft chews.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9